Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-09-16

Clinical Trial Update: Feasibility Study of Ablathermy Focused Ultrasound (USF) of Breast Tumors Before Mastectomy [NA]

View source ↗

Summary

A feasibility study evaluating Ablathermy focused ultrasound for breast tumors prior to mastectomy has been withdrawn from ClinicalTrials.gov.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Institut Bergonié | Conditions: Breast Tumor | NA | Status: WITHDRAWN